{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:08Z","timestamp":1790259908561,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["119955"],"award-info":[{"award-number":["119955"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["27906"],"award-info":[{"award-number":["27906"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["129814"],"award-info":[{"award-number":["129814"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["129814"],"award-info":[{"award-number":["129814"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["092097"],"award-info":[{"award-number":["092097"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["138539"],"award-info":[{"award-number":["138539"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["26160"],"award-info":[{"award-number":["26160"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We have developed a structure-based high-throughput screening (HTS) method, using time-resolved fluorescence resonance energy transfer (TR-FRET) that is sensitive to protein-protein interactions in living cells. The membrane protein complex between the cardiac sarcoplasmic reticulum Ca-ATPase (SERCA2a) and phospholamban (PLB), its Ca-dependent regulator, is a validated therapeutic target for reversing cardiac contractile dysfunction caused by aberrant calcium handling. However, efforts to develop compounds with SERCA2a-PLB specificity have yet to yield an effective drug. We co-expressed GFP-SERCA2a (donor) in the endoplasmic reticulum membrane of HEK293 cells with RFP-PLB (acceptor), and measured FRET using a fluorescence lifetime microplate reader. We screened a small-molecule library and identified 21 compounds (Hits) that changed FRET by &gt;3SD. 10 of these Hits reproducibly alter SERCA2a-PLB structure and function. One compound increases SERCA2a calcium affinity in cardiac membranes but not in skeletal, suggesting that the compound is acting specifically on the SERCA2a-PLB complex, as needed for a drug to mitigate deficient calcium transport in heart failure. The excellent assay quality and correlation between structural and functional assays validate this method for large-scale HTS campaigns. This approach offers a powerful pathway to drug discovery for a wide range of protein-protein interaction targets that were previously considered \u201cundruggable\u201d.<\/jats:p>","DOI":"10.1038\/s41598-018-29685-z","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T10:55:46Z","timestamp":1534416946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Daniel R.","family":"Stroik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevyn A.","family":"Janicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tory M.","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaine K.","family":"Ceholski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-0992","authenticated-orcid":false,"given":"Razvan L.","family":"Cornea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"29685_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrd1343","volume":"3","author":"MR Arkin","year":"2004","unstructured":"Arkin, M. R. & Wells, J. A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3, 301\u2013317, https:\/\/doi.org\/10.1038\/nrd1343 (2004).","journal-title":"Nat Rev Drug Discov"},{"key":"29685_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nature06526","volume":"450","author":"JA Wells","year":"2007","unstructured":"Wells, J. A. & McClendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001\u20131009, https:\/\/doi.org\/10.1038\/nature06526 (2007).","journal-title":"Nature"},{"key":"29685_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","volume":"121","author":"DA Eisner","year":"2017","unstructured":"Eisner, D. A., Caldwell, J. L., Kistamas, K. & Trafford, A. W. Calcium and Excitation-Contraction Coupling in the Heart. Circulation research 121, 181\u2013195, https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310230 (2017).","journal-title":"Circulation research"},{"key":"29685_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan, D. H. & Kranias, E. G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4, 566\u2013577, https:\/\/doi.org\/10.1038\/nrm1151 (2003).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"29685_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198\u2013205, https:\/\/doi.org\/10.1038\/415198a (2002).","journal-title":"Nature"},{"key":"29685_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1517\/14712590903321462","volume":"10","author":"L Lipskaia","year":"2010","unstructured":"Lipskaia, L., Chemaly, E. R., Hadri, L., Lompre, A. M. & Hajjar, R. J. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure. Expert Opin Biol Ther 10, 29\u201341, https:\/\/doi.org\/10.1517\/14712590903321462 (2010).","journal-title":"Expert Opin Biol Ther"},{"key":"29685_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/CIRCULATIONAHA.109.890954","volume":"121","author":"AM Lompre","year":"2010","unstructured":"Lompre, A. M. et al. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 121, 822\u2013830, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.890954 (2010).","journal-title":"Circulation"},{"key":"29685_CR8","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1161\/01.CIR.92.11.3220","volume":"92","author":"RH Schwinger","year":"1995","unstructured":"Schwinger, R. H. et al. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92, 3220\u20133228 (1995).","journal-title":"Circulation"},{"key":"29685_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/01.RES.61.1.70","volume":"61","author":"JK Gwathmey","year":"1987","unstructured":"Gwathmey, J. K. et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circulation research 61, 70\u201376 (1987).","journal-title":"Circulation research"},{"key":"29685_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0008-6363(97)00277-0","volume":"37","author":"G Hasenfuss","year":"1998","unstructured":"Hasenfuss, G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37, 279\u2013289 (1998).","journal-title":"Cardiovasc Res"},{"key":"29685_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0008-6363(98)00110-2","volume":"39","author":"G Hasenfuss","year":"1998","unstructured":"Hasenfuss, G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39, 60\u201376 (1998).","journal-title":"Cardiovasc Res"},{"key":"29685_CR12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm739","volume":"8","author":"M Hoshijima","year":"2002","unstructured":"Hoshijima, M. et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8, 864\u2013871, https:\/\/doi.org\/10.1038\/nm739 (2002).","journal-title":"Nat Med"},{"key":"29685_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1073\/pnas.97.2.793","volume":"97","author":"MI Miyamoto","year":"2000","unstructured":"Miyamoto, M. I. et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proceedings of the National Academy of Sciences of the United States of America 97, 793\u2013798 (2000).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"29685_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.CIR.101.7.790","volume":"101","author":"U Schmidt","year":"2000","unstructured":"Schmidt, U. et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 101, 790\u2013796 (2000).","journal-title":"Circulation"},{"key":"29685_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/gt.2008.120","volume":"15","author":"MJ Byrne","year":"2008","unstructured":"Byrne, M. J. et al. Recirculating cardiac delivery of AAV2\/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 15, 1550\u20131557, https:\/\/doi.org\/10.1038\/gt.2008.120 (2008).","journal-title":"Gene Ther"},{"key":"29685_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","volume":"124","author":"M Jessup","year":"2011","unstructured":"Jessup, M. et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124, 304\u2013313, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.022889 (2011).","journal-title":"Circulation"},{"key":"29685_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","volume":"114","author":"K Zsebo","year":"2014","unstructured":"Zsebo, K. et al. Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circulation research 114, 101\u2013108, https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.302421 (2014).","journal-title":"Circulation research"},{"key":"29685_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/gt.2015.109","volume":"23","author":"B Greenberg","year":"2016","unstructured":"Greenberg, B. et al. Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure. Gene Ther 23, 313\u2013319, https:\/\/doi.org\/10.1038\/gt.2015.109 (2016).","journal-title":"Gene Ther"},{"key":"29685_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1749-6632.1998.tb08305.x","volume":"853","author":"RG Johnson Jr.","year":"1998","unstructured":"Johnson, R. G. Jr. Pharmacology of the cardiac sarcoplasmic reticulum calcium ATPase-phospholamban interaction. Annals of the New York Academy of Sciences 853, 380\u2013392 (1998).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"29685_CR20","doi-asserted-by":"publisher","unstructured":"Cornea, R. L. et al. High-Throughput FRET Assay Yields Allosteric SERCA Activators. J Biomol Screen, 1087057112456878 https:\/\/doi.org\/10.1177\/1087057112456878 (2012).","DOI":"10.1177\/1087057112456878"},{"key":"29685_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1087057113510740","volume":"19","author":"SJ Gruber","year":"2014","unstructured":"Gruber, S. J. et al. Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells. J Biomol Screen 19, 215\u2013222, https:\/\/doi.org\/10.1177\/1087057113510740 (2014).","journal-title":"J Biomol Screen"},{"key":"29685_CR22","doi-asserted-by":"publisher","first-page":"113101","DOI":"10.1063\/1.4900727","volume":"85","author":"KJ Petersen","year":"2014","unstructured":"Petersen, K. J. et al. Fluorescence lifetime plate reader: resolution and precision meet high-throughput. Rev Sci Instrum 85, 113101, https:\/\/doi.org\/10.1063\/1.4900727 (2014).","journal-title":"Rev Sci Instrum"},{"key":"29685_CR23","doi-asserted-by":"publisher","first-page":"35044","DOI":"10.1074\/jbc.M111.266759","volume":"286","author":"P Bidwell","year":"2011","unstructured":"Bidwell, P., Blackwell, D. J., Hou, Z., Zima, A. V. & Robia, S. L. Phospholamban binds with differential affinity to calcium pump conformers. J Biol Chem 286, 35044\u201335050, https:\/\/doi.org\/10.1074\/jbc.M111.266759 (2011).","journal-title":"J Biol Chem"},{"key":"29685_CR24","doi-asserted-by":"publisher","first-page":"14437","DOI":"10.1073\/pnas.0402801101","volume":"101","author":"CB Karim","year":"2004","unstructured":"Karim, C. B., Kirby, T. L., Zhang, Z., Nesmelov, Y. & Thomas, D. D. Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone. Proc Natl Acad Sci USA 101, 14437\u201314442 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29685_CR25","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/S0006-3495(03)74681-5","volume":"85","author":"J Zamoon","year":"2003","unstructured":"Zamoon, J., Mascioni, A., Thomas, D. D. & Veglia, G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys J 85, 2589\u20132598, https:\/\/doi.org\/10.1016\/S0006-3495(03)74681-5 (2003).","journal-title":"Biophys J"},{"key":"29685_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/bip.10365","volume":"69","author":"NA Lockwood","year":"2003","unstructured":"Lockwood, N. A. et al. Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban. Biopolymers 69, 283\u2013292, https:\/\/doi.org\/10.1002\/bip.10365 (2003).","journal-title":"Biopolymers"},{"key":"29685_CR27","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1073\/pnas.0406039102","volume":"102","author":"J Zamoon","year":"2005","unstructured":"Zamoon, J., Nitu, F., Karim, C., Thomas, D. D. & Veglia, G. Mapping the interaction surface of a membrane protein: Unveiling the conformational switch of phospholamban in calcium pump regulation. Proc Natl Acad Sci USA 102, 4747\u20134752 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29685_CR28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jmb.2006.02.051","volume":"358","author":"CB Karim","year":"2006","unstructured":"Karim, C. B., Zhang, Z., Howard, E. C., Torgersen, K. D. & Thomas, D. D. Phosphorylation-dependent Conformational Switch in Spin-labeled Phospholamban Bound to SERCA. J Mol Biol 358, 1032\u20131040 (2006).","journal-title":"J Mol Biol"},{"key":"29685_CR29","doi-asserted-by":"publisher","unstructured":"Li, J., James, Z. M., Dong, X., Karim, C. B. & Thomas, D. D. Structural and functional dynamics of an integral membrane protein complex modulated by lipid headgroup charge. J Mol Biol 418, 379\u2013389, S0022-2836(12)00152-0 https:\/\/doi.org\/10.1016\/j.jmb.2012.02.011 (2012).","DOI":"10.1016\/j.jmb.2012.02.011"},{"key":"29685_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.bpj.2016.08.005","volume":"111","author":"DJ Blackwell","year":"2016","unstructured":"Blackwell, D. J., Zak, T. J. & Robia, S. L. Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer. Biophys J 111, 1192\u20131202, https:\/\/doi.org\/10.1016\/j.bpj.2016.08.005 (2016).","journal-title":"Biophys J"},{"key":"29685_CR31","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1021\/bi049732k","volume":"43","author":"B Mueller","year":"2004","unstructured":"Mueller, B., Karim, C. B., Negrashov, I. V., Kutchai, H. & Thomas, D. D. Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer. Biochemistry 43, 8754\u20138765 (2004).","journal-title":"Biochemistry"},{"key":"29685_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1021\/bi035424v","volume":"43","author":"J Li","year":"2004","unstructured":"Li, J., Xiong, Y., Bigelow, D. J. & Squier, T. C. Phospholamban binds in a compact and ordered conformation to the Ca-ATPase. Biochemistry 43, 455\u2013463, https:\/\/doi.org\/10.1021\/bi035424v (2004).","journal-title":"Biochemistry"},{"key":"29685_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.phytochem.2011.01.015","volume":"72","author":"JM Augustin","year":"2011","unstructured":"Augustin, J. M., Kuzina, V., Andersen, S. B. & Bak, S. Molecular activities, biosynthesis and evolution of triterpenoid saponins. Phytochemistry 72, 435\u2013457, https:\/\/doi.org\/10.1016\/j.phytochem.2011.01.015 (2011).","journal-title":"Phytochemistry"},{"key":"29685_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/9780470559277.ch110252","volume":"4","author":"S Dandapani","year":"2012","unstructured":"Dandapani, S., Rosse, G., Southall, N., Salvino, J. M. & Thomas, C. J. Selecting, Acquiring, and Using Small Molecule Libraries for High-Throughput Screening. Curr Protoc Chem Biol 4, 177\u2013191, https:\/\/doi.org\/10.1002\/9780470559277.ch110252 (2012).","journal-title":"Curr Protoc Chem Biol"},{"key":"29685_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4, 67\u201373, https:\/\/doi.org\/10.1177\/108705719900400206 (1999).","journal-title":"J Biomol Screen"},{"key":"29685_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1087057116680151","volume":"22","author":"TM Schaaf","year":"2017","unstructured":"Schaaf, T. M. et al. High-Throughput Spectral and Lifetime-Based FRET Screening in Living Cells to Identify Small-Molecule Effectors of SERCA. SLAS Discov 22, 262\u2013273, https:\/\/doi.org\/10.1177\/1087057116680151 (2017).","journal-title":"SLAS Discov"},{"key":"29685_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/1087057116679637","volume":"22","author":"TM Schaaf","year":"2017","unstructured":"Schaaf, T. M., Peterson, K. C., Grant, B. D., Thomas, D. D. & Gillispie, G. D. Spectral Unmixing Plate Reader: High-Throughput, High-Precision FRET Assays in Living Cells. SLAS Discov 22, 250\u2013261, https:\/\/doi.org\/10.1177\/1087057116679637 (2017).","journal-title":"SLAS Discov"},{"key":"29685_CR38","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes, J. P., Rees, S., Kalindjian, S. B. & Philpott, K. L. Principles of early drug discovery. Br J Pharmacol 162, 1239\u20131249, https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01127.x (2011).","journal-title":"Br J Pharmacol"},{"key":"29685_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/bj20020431","volume":"366","author":"JG Bilmen","year":"2002","unstructured":"Bilmen, J. G., Wootton, L. L. & Michelangeli, F. The inhibition of the sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A. Biochem J 366, 255\u2013263, https:\/\/doi.org\/10.1042\/BJ20020431 (2002).","journal-title":"Biochem J"},{"key":"29685_CR40","first-page":"III21","volume":"81","author":"JP Morgan","year":"1990","unstructured":"Morgan, J. P., Erny, R. E., Allen, P. D., Grossman, W. & Gwathmey, J. K. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81, III21\u201332 (1990).","journal-title":"Circulation"},{"key":"29685_CR41","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1006\/jmcc.1998.0748","volume":"30","author":"U Schmidt","year":"1998","unstructured":"Schmidt, U. et al. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol 30, 1929\u20131937, https:\/\/doi.org\/10.1006\/jmcc.1998.0748 (1998).","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl 1","key":"29685_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00794072","volume":"92","author":"G Hasenfuss","year":"1997","unstructured":"Hasenfuss, G. et al. Calcium handling proteins in the failing human heart. Basic Res Cardiol 92(Suppl 1), 87\u201393 (1997).","journal-title":"Basic Res Cardiol"},{"key":"29685_CR43","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.RES.75.3.434","volume":"75","author":"G Hasenfuss","year":"1994","unstructured":"Hasenfuss, G. et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75, 434\u2013442 (1994).","journal-title":"Circ Res"},{"issue":"Suppl 2","key":"29685_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00795357","volume":"91","author":"G Hasenfuss","year":"1996","unstructured":"Hasenfuss, G. et al. Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol 91(Suppl 2), 17\u201322 (1996).","journal-title":"Basic Res Cardiol"},{"key":"29685_CR45","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1073\/pnas.0305778101","volume":"101","author":"F del Monte","year":"2004","unstructured":"del Monte, F. et al. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci USA 101, 5622\u20135627, https:\/\/doi.org\/10.1073\/pnas.0305778101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29685_CR46","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/hc3601.095574","volume":"104","author":"F del Monte","year":"2001","unstructured":"del Monte, F. et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 104, 1424\u20131429 (2001).","journal-title":"Circulation"},{"key":"29685_CR47","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jacc.2007.12.014","volume":"51","author":"Y Kawase","year":"2008","unstructured":"Kawase, Y. et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 51, 1112\u20131119, https:\/\/doi.org\/10.1016\/j.jacc.2007.12.014 (2008).","journal-title":"J Am Coll Cardiol"},{"key":"29685_CR48","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1081578","volume":"299","author":"JP Schmitt","year":"2003","unstructured":"Schmitt, J. P. et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410\u20131413, https:\/\/doi.org\/10.1126\/science.1081578 (2003).","journal-title":"Science"},{"key":"29685_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvv127","volume":"107","author":"GS Liu","year":"2015","unstructured":"Liu, G. S. et al. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res 107, 164\u2013174, https:\/\/doi.org\/10.1093\/cvr\/cvv127 (2015).","journal-title":"Cardiovasc Res"},{"key":"29685_CR50","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1172\/JCI17892","volume":"111","author":"K Haghighi","year":"2003","unstructured":"Haghighi, K. et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111, 869\u2013876, https:\/\/doi.org\/10.1172\/JCI17892 (2003).","journal-title":"J Clin Invest"},{"key":"29685_CR51","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bbamem.2018.02.030","volume":"1860","author":"SED Nelson","year":"2018","unstructured":"Nelson, S. E. D. et al. Effects of the Arg9Cys and Arg25Cys mutations on phospholamban\u2019s conformational equilibrium in membrane bilayers. Biochim Biophys Acta 1860, 1335\u20131341, https:\/\/doi.org\/10.1016\/j.bbamem.2018.02.030 (2018).","journal-title":"Biochim Biophys Acta"},{"key":"29685_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00210-009-0483-z","volume":"381","author":"PH Pimenta","year":"2010","unstructured":"Pimenta, P. H., Silva, C. L. & Noel, F. Ivermectin is a nonselective inhibitor of mammalian P-type ATPases. Naunyn Schmiedebergs Arch Pharmacol 381, 147\u2013152, https:\/\/doi.org\/10.1007\/s00210-009-0483-z (2010).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"29685_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0167-7799(97)01166-9","volume":"16","author":"KA Giuliano","year":"1998","unstructured":"Giuliano, K. A. & Taylor, D. L. Fluorescent-protein biosensors: new tools for drug discovery. Trends Biotechnol 16, 135\u2013140, https:\/\/doi.org\/10.1016\/S0167-7799(97)01166-9 (1998).","journal-title":"Trends Biotechnol"},{"key":"29685_CR54","doi-asserted-by":"publisher","first-page":"E1796","DOI":"10.1073\/pnas.1611698114","volume":"114","author":"JA Rohde","year":"2017","unstructured":"Rohde, J. A., Thomas, D. D. & Muretta, J. M. Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke. Proc Natl Acad Sci USA 114, E1796\u2013E1804, https:\/\/doi.org\/10.1073\/pnas.1611698114 (2017).","journal-title":"Proc Natl Acad Sci USA"},{"key":"29685_CR55","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1177\/2472555217706478","volume":"22","author":"CH Lo","year":"2017","unstructured":"Lo, C. H. et al. An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors. SLAS Discov 22, 950\u2013961, https:\/\/doi.org\/10.1177\/2472555217706478 (2017).","journal-title":"SLAS Discov"},{"key":"29685_CR56","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/1087057116674312","volume":"22","author":"RT Rebbeck","year":"2017","unstructured":"Rebbeck, R. T. et al. High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels. SLAS discovery: advancing life sciences R & D 22, 176\u2013186, https:\/\/doi.org\/10.1177\/1087057116674312 (2017).","journal-title":"SLAS discovery: advancing life sciences R & D"},{"key":"29685_CR57","doi-asserted-by":"publisher","unstructured":"Vogel, S. S., Thaler, C. & Koushik, S. V. Fanciful FRET. Sci STKE 2006, re2, https:\/\/doi.org\/10.1126\/stke.3312006re2 (2006).","DOI":"10.1126\/stke.3312006re2"},{"key":"29685_CR58","doi-asserted-by":"publisher","first-page":"e49593","DOI":"10.1371\/journal.pone.0049593","volume":"7","author":"SS Vogel","year":"2012","unstructured":"Vogel, S. S., Nguyen, T. A., van der Meer, B. W. & Blank, P. S. The impact of heterogeneity and dark acceptor states on FRET: implications for using fluorescent protein donors and acceptors. PLoS One 7, e49593, https:\/\/doi.org\/10.1371\/journal.pone.0049593 (2012).","journal-title":"PLoS One"},{"key":"29685_CR59","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/978-1-4939-3179-8_42","volume":"1377","author":"B Svensson","year":"2016","unstructured":"Svensson, B., Autry, J. M. & Thomas, D. D. Molecular Modeling of Fluorescent SERCA Biosensors. Methods Mol Biol 1377, 503\u2013522, https:\/\/doi.org\/10.1007\/978-1-4939-3179-8_42 (2016).","journal-title":"Methods Mol Biol"},{"key":"29685_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbrc.2014.04.166","volume":"449","author":"X Dong","year":"2014","unstructured":"Dong, X. & Thomas, D. D. Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation. Biochem Biophys Res Commun 449, 196\u2013201, https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.166 (2014).","journal-title":"Biochem Biophys Res Commun"},{"key":"29685_CR61","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.bpj.2013.08.045","volume":"105","author":"S Pallikkuth","year":"2013","unstructured":"Pallikkuth, S. et al. Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase. Biophys J 105, 1812\u20131821, https:\/\/doi.org\/10.1016\/j.bpj.2013.08.045 (2013).","journal-title":"Biophys J"},{"key":"29685_CR62","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.bpj.2012.08.032","volume":"103","author":"ZM James","year":"2012","unstructured":"James, Z. M., McCaffrey, J. E., Torgersen, K. D., Karim, C. B. & Thomas, D. D. Protein-protein interactions in calcium transport regulation probed by saturation transfer electron paramagnetic resonance. Biophys J 103, 1370\u20131378, https:\/\/doi.org\/10.1016\/j.bpj.2012.08.032 (2012).","journal-title":"Biophys J"},{"key":"29685_CR63","doi-asserted-by":"crossref","unstructured":"Hou, Z. et al. Two-color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding. PLoS ONE, accepted (2012).","DOI":"10.1371\/journal.pone.0040369"},{"key":"29685_CR64","doi-asserted-by":"publisher","unstructured":"Gruber, S. J., Haydon, S. & Thomas, D. D. Phospholamban mutants compete with wild type for SERCA binding in living cells. Biochem Biophys Res Commun 420, 236\u2013240, S0006-291X(12)00384-1 https:\/\/doi.org\/10.1016\/j.bbrc.2012.02.125 (2012).","DOI":"10.1016\/j.bbrc.2012.02.125"},{"key":"29685_CR65","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCRESAHA.107.159947","volume":"101","author":"SL Robia","year":"2007","unstructured":"Robia, S. L. et al. Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex. Circ Res 101, 1123\u20131129 (2007).","journal-title":"Circ Res"},{"key":"29685_CR66","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv, S. et al. p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282, 24131\u201324145, https:\/\/doi.org\/10.1074\/jbc.M702824200 (2007).","journal-title":"J Biol Chem"},{"key":"29685_CR67","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature13133","volume":"509","author":"N Nakamura","year":"2014","unstructured":"Nakamura, N. et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509, 240\u2013244, https:\/\/doi.org\/10.1038\/nature13133 (2014).","journal-title":"Nature"},{"key":"29685_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tox.2008.06.009","volume":"250","author":"LM Aleksunes","year":"2008","unstructured":"Aleksunes, L. M., Augustine, L. M., Scheffer, G. L., Cherrington, N. J. & Manautou, J. E. Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 250, 82\u201388, https:\/\/doi.org\/10.1016\/j.tox.2008.06.009 (2008).","journal-title":"Toxicology"},{"key":"29685_CR69","doi-asserted-by":"crossref","unstructured":"Muretta, J. M. et al. High -performance time-resolved fluorescence by direct waveform recording. Rev Sci Instrum 81, 103101-103101 - 103101-103108 (2010).","DOI":"10.1063\/1.3480647"},{"key":"29685_CR70","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1073\/pnas.1012320108","volume":"108","author":"YE Nesmelov","year":"2011","unstructured":"Nesmelov, Y. E. et al. Structural kinetics of myosin by transient time-resolved FRET. Proceedings of the National Academy of Sciences of the United States of America 108, 1891\u20131896, https:\/\/doi.org\/10.1073\/pnas.1012320108 (2011).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"29685_CR71","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.1073\/pnas.1222257110","volume":"110","author":"JM Muretta","year":"2013","unstructured":"Muretta, J. M., Petersen, K. J. & Thomas, D. D. Direct real-time detection of the actin-activated power stroke within the myosin catalytic domain. Proceedings of the National Academy of Sciences of the United States of America 110, 7211\u20137216, https:\/\/doi.org\/10.1073\/pnas.1222257110 (2013).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"29685_CR72","doi-asserted-by":"publisher","first-page":"C724","DOI":"10.1152\/ajpcell.2000.279.3.C724","volume":"279","author":"BR Fruen","year":"2000","unstructured":"Fruen, B. R., Bardy, J. M., Byrem, T. M., Strasburg, G. M. & Louis, C. F. Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin. American journal of physiology. Cell physiology 279, C724\u2013733 (2000).","journal-title":"Cell physiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29685-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29685-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29685-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:35:37Z","timestamp":1671611737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29685-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29685-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"23 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: DDT and RLC hold equity in, and serve as executive officers for, Photonic Pharma LLC. These relationships have been reviewed and managed by the University of Minnesota. Photonic Pharma had no role in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12560"}}